These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 26381898)

  • 1. Improved oral absorption of exenatide using an original nanoencapsulation and microencapsulation approach.
    Soudry-Kochavi L; Naraykin N; Nassar T; Benita S
    J Control Release; 2015 Nov; 217():202-10. PubMed ID: 26381898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of low molecular weight protamine to enhance oral absorption of exenatide.
    Zhang L; Shi Y; Song Y; Sun X; Zhang X; Sun K; Li Y
    Int J Pharm; 2018 Aug; 547(1-2):265-273. PubMed ID: 29800739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An approach for half-life extension and activity preservation of an anti-diabetic peptide drug based on genetic fusion with an albumin-binding aptide.
    Kim D; Jeon H; Ahn S; Choi WI; Kim S; Jon S
    J Control Release; 2017 Jun; 256():114-120. PubMed ID: 28457895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overcoming the diffusion barrier of mucus and absorption barrier of epithelium by self-assembled nanoparticles for oral delivery of insulin.
    Shan W; Zhu X; Liu M; Li L; Zhong J; Sun W; Zhang Z; Huang Y
    ACS Nano; 2015 Mar; 9(3):2345-56. PubMed ID: 25658958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thiolated Eudragit nanoparticles for oral insulin delivery: preparation, characterization and in vivo evaluation.
    Zhang Y; Wu X; Meng L; Zhang Y; Ai R; Qi N; He H; Xu H; Tang X
    Int J Pharm; 2012 Oct; 436(1-2):341-50. PubMed ID: 22766443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The glucose-lowering potential of exenatide delivered orally via goblet cell-targeting nanoparticles.
    Li X; Wang C; Liang R; Sun F; Shi Y; Wang A; Liu W; Sun K; Li Y
    Pharm Res; 2015 Mar; 32(3):1017-27. PubMed ID: 25270570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sol-gel transition of nanoparticles/polymer mixtures for sustained delivery of exenatide to treat type 2 diabetes mellitus.
    Oh KS; Kim JY; Yoon BD; Lee M; Kim H; Kim M; Seo JH; Yuk SH
    Eur J Pharm Biopharm; 2014 Nov; 88(3):664-9. PubMed ID: 25152212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of CSK-DEX-PLGA Nanoparticles for the Oral Delivery of Exenatide to Improve Its Mucus Penetration and Intestinal Absorption.
    Song Y; Shi Y; Zhang L; Hu H; Zhang C; Yin M; Chu L; Yan X; Zhao M; Zhang X; Mu H; Sun K
    Mol Pharm; 2019 Feb; 16(2):518-532. PubMed ID: 30601014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biological activity of AC3174, a peptide analog of exendin-4.
    Hargrove DM; Kendall ES; Reynolds JM; Lwin AN; Herich JP; Smith PA; Gedulin BR; Flanagan SD; Jodka CM; Hoyt JA; McCowen KM; Parkes DG; Anderson CM
    Regul Pept; 2007 Jun; 141(1-3):113-9. PubMed ID: 17292977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eudragit® L100-coated mannosylated chitosan nanoparticles for oral protein vaccine delivery.
    Xu B; Zhang W; Chen Y; Xu Y; Wang B; Zong L
    Int J Biol Macromol; 2018 Jul; 113():534-542. PubMed ID: 29408613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral delivery system for low molecular weight protamine-dextran-poly(lactic-co-glycolic acid) carrying exenatide to overcome the mucus barrier and improve intestinal targeting efficiency.
    Song Y; Shi Y; Zhang L; Hu H; Zhang C; Yin M; Zhang X; Sun K
    Nanomedicine (Lond); 2019 Apr; 14(8):989-1009. PubMed ID: 31088322
    [No Abstract]   [Full Text] [Related]  

  • 12. Combination therapy via oral co-administration of insulin- and exendin-4-loaded nanoparticles to treat type 2 diabetic rats undergoing OGTT.
    Chuang EY; Nguyen GT; Su FY; Lin KJ; Chen CT; Mi FL; Yen TC; Juang JH; Sung HW
    Biomaterials; 2013 Oct; 34(32):7994-8001. PubMed ID: 23891516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacodynamical effects of orally administered exenatide nanoparticles embedded in gastro-resistant microparticles.
    Soudry-Kochavi L; Naraykin N; Di Paola R; Gugliandolo E; Peritore A; Cuzzocrea S; Ziv E; Nassar T; Benita S
    Eur J Pharm Biopharm; 2018 Dec; 133():214-223. PubMed ID: 30342089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and pharmacodynamics of exenatide following alternate routes of administration.
    Gedulin BR; Smith PA; Jodka CM; Chen K; Bhavsar S; Nielsen LL; Parkes DG; Young AA
    Int J Pharm; 2008 May; 356(1-2):231-8. PubMed ID: 18291606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effective oral delivery of insulin in animal models using vitamin B12-coated dextran nanoparticles.
    Chalasani KB; Russell-Jones GJ; Jain AK; Diwan PV; Jain SK
    J Control Release; 2007 Sep; 122(2):141-50. PubMed ID: 17707540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro and in vivo sustained release of exenatide from vesicular phospholipid gels for type II diabetes.
    Zhang Y; Zhong Y; Hu M; Xiang N; Fu Y; Gong T; Zhang Z
    Drug Dev Ind Pharm; 2016; 42(7):1042-9. PubMed ID: 26558908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Self-nanoemulsifying drug delivery systems for oral insulin delivery: in vitro and in vivo evaluations of enteric coating and drug loading.
    Li P; Tan A; Prestidge CA; Nielsen HM; Müllertz A
    Int J Pharm; 2014 Dec; 477(1-2):390-8. PubMed ID: 25455781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphatic uptake of the lipidated and non-lipidated GLP-1 agonists liraglutide and exenatide is similar in rats.
    Reddiar SB; Abdallah M; Styles IK; Müllertz OO; Trevaskis NL
    Eur J Pharm Biopharm; 2024 Jul; 200():114339. PubMed ID: 38789061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eudragit S100-Coated Chitosan Nanoparticles Co-loading Tat for Enhanced Oral Colon Absorption of Insulin.
    Chen S; Guo F; Deng T; Zhu S; Liu W; Zhong H; Yu H; Luo R; Deng Z
    AAPS PharmSciTech; 2017 May; 18(4):1277-1287. PubMed ID: 27480441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exendin-4 Loaded Nanoparticles with a Lipid Shell and Aqueous Core Containing Micelles for Enhanced Intestinal Absorption.
    Chen C; Zhu X; Dou Y; Xu J; Zhang J; Fan T; Du J; Liu K; Deng Y; Zhao L; Huang Y
    J Biomed Nanotechnol; 2015 May; 11(5):865-76. PubMed ID: 26349398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.